Viser 320 bedrifter for "Pharmaceuticals"
Bedrifter
Corvus Pharmaceuticals, Inc.
Corvus is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of immune diseases and cancer. Their lead program, soquelitinib, is a first-in-class, oral therapy that selectively inhibits ITK. The company focuses on advancing soquelitinib and collaborates to advance other clinical-stage programs. They are known for putting patients first and promptly reporting clinical data.
COMPASS Pathways plc
Compass Pathways is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. They are studying investigational psilocybin treatment in treatment-resistant depression, post-traumatic stress disorder and anorexia nervosa. The company aims to connect science and compassion to reimagine mental health care.
BIOCRYST PHARMACEUTICALS INC
BioCryst is a biotechnology company focused on discovering, developing, and commercializing novel medicines, particularly for rare diseases. They are world leaders in structure-guided drug design, focusing on oral small-molecule and protein therapeutics. The company is known for its commitment to delivering first-in-class or best-in-class treatments.
Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc. is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. They focus on changing the narrative around viral skin diseases and making treatment more efficient. Their lead product, YCANTH®, is approved for the treatment of molluscum contagiosum. They are also developing VP-315 for the treatment of dermatologic oncologic conditions.
Editas Medicine, Inc.
Editas Medicine is a pioneering gene editing company focused on developing transformative medicines using CRISPR/Cas9 and CRISPR/Cas12a genome editing systems. They aim to discover, develop, manufacture, and commercialize precise genomic medicines for a broad range of serious diseases worldwide. The company's pipeline includes experimental medicines focused on in vivo gene editing and other innovative approaches. Editas Medicine is headquartered in Cambridge, MA, with a site in Boulder, CO.
Galecto, Inc.
Galecto develops small molecules for the treatment of severe diseases, including cancer and fibrosis. The company focuses on modulators of galectin-3 and ENL/YEATS / FLT3 to treat cancer and severe liver diseases. Galecto has a unique therapeutic platform and aims to improve patient treatments.
Amylyx Pharmaceuticals, Inc.
Amylyx is a clinical-stage pharmaceutical company dedicated to developing novel therapies for diseases with high unmet needs. They focus on innovative treatments in neurodegenerative diseases and metabolic disorders. Key products include AMX0035 for ALS and avexitide for post-bariatric hypoglycemia (PBH). The company is committed to delivering with speed and rigor.
Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals is a global pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for endocrine disease and endocrine-related tumors. Their mission is to build the world’s leading endocrine company that pioneers new therapeutics to help patients better control their disease and improve their daily lives. They focus on innovative molecules with a focus on the endocrine system and G-protein coupled receptors.
Mirum Pharmaceuticals, Inc.
Mirum develops safe and effective therapies for people with rare diseases, aiming to improve the lives of patients and their families. They focus on providing medicines and treatments for rare liver diseases and metabolic disorders, striving to fill a therapeutic void. Mirum is committed to developing remarkable therapies for these conditions, with a strong emphasis on patient needs and transformative scientific discoveries.
Akebia Therapeutics, Inc.
Akebia Therapeutics is a fully integrated biopharmaceutical company developing and commercializing unique therapeutics for people with kidney disease. With two FDA-approved products, they are a leader in the renal community. The company collaborates with medical professionals and patient organizations to better the lives of those affected by kidney disease.
LIFECORE BIOMEDICAL, INC. DE
Lifecore Biomedical is a CDMO (Contract Development and Manufacturing Organization) specializing in the development and manufacturing of injectable pharmaceuticals and medical devices. They offer expertise in formulation, aseptic filling, and packaging. With over 40 years of experience and international certifications, the company emphasizes its commitment to quality and compliance.
Lantheus Holdings, Inc.
Lantheus is a leading radiopharmaceutical-focused company dedicated to delivering life-changing science to improve patient outcomes. They specialize in the development, manufacture, and commercialization of innovative diagnostic and therapeutic products. With a 70-year history, Lantheus is a key player in oncology, neurology, and other therapeutic areas.
Cartesian Therapeutics, Inc.
Cartesian Therapeutics is a clinical-stage company pioneering mRNA cell therapies for the treatment of autoimmune diseases. Leveraging their novel mRNA platform, they are committed to expanding the reach of cell therapy to patients. The company is dedicated to putting patients at the center of innovation, focused on bringing treatments for autoimmune disorders into the 21st century.
Astria Therapeutics, Inc.
Astria Therapeutics is a biopharmaceutical company focused on discovering and developing therapies for rare and niche diseases. They are committed to addressing unmet needs and improving the quality of life for patients, with a focus on scientific innovation and compassion. Their pipeline includes Navenibart (STAR-0215) and STAR-0310, targeting specific therapeutic areas. They are guided by a patient-centric approach emphasizing urgency and operational efficiency.
Winpak Ltd./ADR
Winpak is a global packaging group with manufacturing facilities in North America. They manufacture and distribute packaging materials and machines primarily for perishable foods, beverages, pharmaceuticals, medical, and personal care. Winpak specializes in flexible packaging, rigid packaging & lidding, and packaging machinery. They partner with Wipak to offer a broad range of packaging solutions globally.
Salarius Pharmaceuticals, Inc.
Salarius Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapies for cancer patients in need of new treatment options. They focus on correcting dysregulated gene expression in cancer cells through targeted protein inhibition and targeted protein degradation. Their lead protein inhibitor, seclidemstat (SP-2577), is in phase 1/2 trials, and their TPD drug SP-3164 is in IND-enabling studies. Salarius is the recipient of a CPRIT award and is located in the Texas Medical Center Innovation facility.
Spyre Therapeutics, Inc.
Spyre Therapeutics is developing next-generation antibodies engineered for prolonged activity and formulated for delivery as monotherapies or combination therapies. Their innovative approach enables the exploration of treatment options with the potential to deliver uncompromising efficacy and convenience. They target IBD and other immune-mediated diseases. Their pipeline includes novel antibodies targeting validated mechanisms with potential to treat gastrointestinal and rheumatic conditions.
Kezar Life Sciences, Inc.
Kezar Life Sciences develops innovative small molecule therapies targeting intracellular proteins to inhibit disease-driving cellular pathways. They focus on Selective Immunoproteasome Inhibition for autoimmune diseases and Protein Secretion Inhibition for cancer and autoimmune diseases. Their mission is to deliver unique treatments for difficult-to-treat chronic diseases.
Zentalis Pharmaceuticals, Inc.
Zentalis is a clinical-stage biopharmaceutical company focused on discovering and developing differentiated small molecule therapeutics targeting fundamental biological pathways of cancers. Utilizing its Integrated Discovery Engine, the Company is developing a focused pipeline of potentially best-in-class oncology candidates, which include azenosertib, a WEE1 inhibitor for advanced solid tumors. They also advance research on protein degraders.
CAMPUSPHARMA AB
CampusPharma registrerer og markedsfører legemidler og egenomsorgsprodukter i Norden, med fokus på kvinnehelse. De tilbyr produkter innen områder som bakteriell vaginose, svangerskapskvalme, menopause og nevrologi. Natalben er et kosttilskudd for gravide og ammende mødre, og Postafen er et reseptfritt legemiddel mot reisesyke.